TY - JOUR A1 - Horn, Lars-Christian A1 - Raptis, Georgios A1 - Fischer, Uta A1 - Hentschel, Bettina A1 - Köhler, U. A1 - Richter, Christine E. A1 - Martin, Rosemarie T1 - CD44-v6 concentrations in carcinoma of the uterine cervix: lack of prognostic significance JF - Archives of Gynecology and Obstetrics N2 - Several kinds of cellular adhesion molecules, like different splicing variants of CD 44, have gained important as prognostic or markers for metastatic disease. Fresh frozen samples from 64 cervical carcinoma (CX) were stored in liquid nitrogen and examined using ELISA-technique, testing the prognostic impact. Normal cervical tissue served as control. CD 44-v6 concentration, was significant elevated in tumor tissue, when compared to the controls (P=0.04). There was no correlation to tumor stage (P=0.61), lymphovascular space involvement (P=0.075) or pelvic lymph node involvement (P=0.81). The CD 44-v6 concentration was not informative regarding recurrence-free and overall survival. Contrary to immunohistochemistry, the quantification of CD 44-v6 using ELISA-technique does not provide any further information. KW - Gebärmutterhalskrebs KW - Antigen CD44 Y1 - 2005 U6 - https://doi.org/10.1007/s00404-005-0039-5 VL - 273 IS - 2 SP - 104 EP - 106 ER - TY - CHAP A1 - Wiesmaier, Alexander A1 - Lippert, Markus A1 - Karatsiolis, Vangelis A1 - Raptis, Georgios A1 - Buchmann, Johannes T1 - An Evaluated Certification Services System for the German National Root CA - Legally Binding and Trustworthy Transactions in E-Business and E-Government T2 - Proceedings of The 2005 International Conference on E-Business, Enterprise Information Systems, E-Government, and Outsourcing, EEE 2005, Las Vegas, Nevada, USA, June 20-23, 2005 Y1 - 2005 SN - 1-932415-76-9 SP - 103 EP - 108 PB - CSREA Press ER - TY - JOUR A1 - Busch, Ch. A1 - Daum, H. A1 - Raptis, Georgios T1 - Merkmal Iris. Können diese Augen lügen? JF - Spektrum der Wissenschaft KW - Biometrie KW - Mustererkennung KW - Iris KW - Regenbogenhaut Y1 - 2003 UR - https://www.spektrum.de/magazin/koennen-diese-augen-luegen/829906 IS - 7 SP - 81 EP - 82 ER - TY - GEN A1 - Raptis, Georgios T1 - Mögliche Auswirkungen der eIDAS-Verordnung auf die Telematikinfrastruktur und die eArztausweise BT - Vortrag T2 - CAST-Workshop PKI, Darmstadt, 29.01.2015 KW - Europäische Union KW - Telemedizin KW - eArztausweis KW - Elektronischer Arztausweis Y1 - 2015 ER - TY - BOOK A1 - Sauer, S. A1 - Wolf, Th. A1 - Buch, M. A1 - Raptis, Georgios T1 - Sichere Client-Server-Architekturen für E-Government BT - E-Government-Handbuch KW - Client-Server-Konzept KW - Datensicherheit KW - E-Government Y1 - 2004 ER - TY - GEN A1 - Raptis, Georgios T1 - HPCs als Basis für den elektronischen Arztausweis BT - Vortrag T2 - Smartcard-Workshops, Fraunhofer SIT, 07.02.2006 KW - Arzt KW - Ausweis KW - Hochleistungsrechnen Y1 - 2006 ER - TY - THES A1 - Raptis, Georgios T1 - Klassifikation, Anwendungen und Sicherheitskonzept von Trustcentern KW - Trust Center Y1 - 2004 ER - TY - GEN A1 - Raptis, Georgios T1 - Datenschutzfragen zur Telemedizin BT - Vortrag T2 - Fachtagung Datenschutz in der Medizin - Update 2015 I, Hamburg 03.02.2015 KW - Telemedizin KW - Datenschutz Y1 - 2015 ER - TY - JOUR A1 - Raptis, Georgios T1 - Kryptographischer Langzeitschutz JF - KES - The Information Security Journal KW - Kryptologie KW - Datensicherung Y1 - 2008 VL - 1 SP - 55 EP - 62 ER - TY - JOUR A1 - Raptis, Georgios T1 - Computer können Ärzte nicht ersetzen BT - Interview JF - Technology Review Y1 - 2014 VL - 11 SP - 82 ER - TY - JOUR A1 - Horn, Lars-Christian A1 - Fischer, Uta A1 - Raptis, Georgios A1 - Bilek, Karin A1 - Hentschel, Bettina A1 - Richter, Christine E. A1 - Braumann, Ulf Dietrich A1 - Einenkel, Jens T1 - Pattern of invasion is of prognostic value in surgically treated cervical cancer patients JF - Gynecologic Oncology N2 - Objectives: Different patterns of invasion (representing different grades of tumor cell dissociation) are associated with prognostic outcome in cancer. We evaluated the prognostic value of different patterns of invasion (PI) in cervical carcinomas (CX). Methods: Six hundred eleven surgically treated CX (FIGO IB to IIB) were re-evaluated histologically regarding the PI, using a three-level scoring system. Closed PI was defined as cohesive growth with well-delineated (pushing) borders. In finger-like PI the tumor grows in solid cords/trabecles. Highly dissociative growth in small groups or single cells was defined as spray-like PI. Types of PI were correlated to tumor stage, histo-morphologic factors and prognostic outcome. Results: Sixty percent of the tumors showed a spray-like PI, 30% a finger-like PI and only 7.4% were of the closed type. Spray-like PI showed a significant correlation with advanced stage disease, lymphovascular space involvement, poorly differentiated tumors and pelvic lymph node metastases. Spray-like PI was accompanied by a reduced 5-year overall survival when compared to the finger-like and closed PI (68.7% vs. 80.9% vs. 88.5%; P=0.0004). The prognostic impact of the PI disappeared in node-positive patients (P=0.06) but persisted in patients without pelvic lymph node disease (P=0.03). In multivariate analysis, using COX regression model, the PI represented as independent prognostic factor. Conclusions: Spray-like PI (i.e., highest degree of tumor cell dissociation) is associated with advanced tumor stages, increased rate of recurrency and a reduced overall survival. In separate analysis of patients with and without lymph node metastases, the impact of PI persisted only in node-negative cases as a prognostic factor. KW - Gebärmutterhalskrebs KW - Chirurgie KW - Metastase Y1 - 2006 U6 - https://doi.org/10.1016/j.ygyno.2006.05.046 VL - 103 IS - 3 SP - 906 EP - 911 ER - TY - JOUR A1 - Horn, Lars-Christian A1 - Fischer, Uta A1 - Raptis, Georgios A1 - Bilek, Karin A1 - Hentschel, Bettina T1 - Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer JF - Gynecologic Oncology N2 - Objectives Tumor size is a well recognized prognostic factor in early stage cervical carcinoma (CX). However, limited knowledge exists about the value of tumor size in surgically treated CX with extrauterine extension. Methods 245 cases of local advanced CX (FIGO stage IIA and IIB) who received upfront surgery were evaluated regarding tumor size, regarding the prediction of pelvic lymph node involvement and recurrence free and overall survival during a median follow-up time of 54 months (95% CI 45.4–62.6 months). Tumors larger than 4 cm were defined as bulky stage disease. Results Bulky disease was seen in 46.1% (113/245). 60.2% of these patients showed pelvic lymph node involvement, compared to 42.4% (56/132) in non-bulky tumors (p = 0.006; odds ratio: 2.2 [95% CI: 1.3–3.6]). Patients with bulky tumors showed an increase of recurrent disease (40.2% vs. 28.0%; p = 0.045). The relative risk for recurrent disease was 1.97 (95% CI: 1.3–3.0). The 5-year overall survival rate was significantly lower (67.7% [95% CI: 58.2–74.8] vs. 49.5% [95% CI: 36.8–59.1]; p = 0.0015). In multivariate analysis, tumor stage, pelvic lymph node involvement and maximal tumor size were independent prognostic factors. Conclusions The results suggest that tumor size, defining bulky disease as tumors larger than 4 cm, is of prognostic impact also in FIGO stage II cervical carcinomas. A revised FIGO/TNM classification system similar to the subgrouping of stage IB CX is recommended for stage II using a cut-off value of 4 cm as discriminator: stage IIA1 and stage IIB1 for tumors with ≤ 4 cm and IIA2 and IIB2 for tumors > 4 cm (i.e. bulky disease). KW - Gebärmutterhalskrebs KW - Chirurgie KW - Tumorwachstum Y1 - 2007 U6 - https://doi.org/10.1016/j.ygyno.2007.06.026 VL - 107 IS - 2 SP - 310 EP - 315 ER - TY - CHAP A1 - Höh, H. A1 - Raptis, Georgios T1 - Applications of the Erbium: YAG Laser in Ophthalmology - Cataracta-, Glaukoma-, Eyelid-Surgery and pars plana Vitrectomy BT - Symposium on Cataract, IOL, and Refractive Surgery. Boston, 20.05.2000 und 22.05.2000 N2 - Recent developments in lasers have provided us the possibility of laser ocular surgery. The xenon, argon, neodymium:YAG and dye lasers have been successfully used in out-patient clinics. The excimer laser has been attracting researchers' interest in the new application of laser to cornea and lens. The erbium:YAG laser emits a 2.94-microns beam that can ablate the transparent ocular tissues such as lenses and corneas. The author has applied this laser to the cornea, lens, vitreous and other ocular tissues. The erbium:YAG laser beam was directed through a 1.5-meter-long, 200-microns-diameter fiberoptic guide. The radiant energy measured about 50 mJ at the end of the probe. The laser was emitted as a 400-microsecond pulse. Freshly enucleated rabbit eyes were used in this study. Laser burns were applied to the tissue surface at various energy settings. At minimal power, the tissues were coagulated by the erbium:YAG laser application. At a power of more than 636-954 mJ/mm2, tissue began to evaporate; the tissue loss was observed under a surgical light microscope. Corneal photoablation, lens ablation, iridotomy, trabeculotomy, cutting of the vitreous and retinal ablation were easily performed. Like the excimer laser, the erbium:YAG laser is a potential tool for ocular surgery. KW - Augenchirurgie KW - YAG-Laser KW - Erbium-Laser Y1 - 2000 ER - TY - JOUR A1 - Chaloupka, I. A1 - Raptis, Georgios A1 - Zach, A. A1 - Brändlin, K. A1 - Meier-Ewert, H. T1 - Rolle der quantitativen CMV-DNA-Bestimmungen in der Diagnostik und Therapie der Cytomegalovirusinfektion bei immunsupprimierten Patienten BT - Vortrag JF - Jahrestagung der Gesellschaft für Virologie in Wien, April 2000 KW - Cytomegalie-Virus KW - Diagnose KW - Immunsuppresion Y1 - 2000 ER - TY - CHAP A1 - Horn, Lars-Christian A1 - Pippig, S. A1 - Raptis, Georgios A1 - Fischer, Uta A1 - Köhler, U. A1 - Hentschel, Bettina A1 - Martin, Rosemarie T1 - Tumorassoziierte Proteolyse beim Zervixkarzinom BT - Vortrag T2 - 87. Tagung der Deutschen Gesellschaft für Pathologie, 14. Juni 2003 KW - Gebärmutterhalskrebs KW - Chirurgie KW - Tumorassoziierte Proteolyse KW - Immuncytochemie KW - Zelladhäsion Y1 - 2003 ER - TY - GEN A1 - Horn, Lars-Christian A1 - Raptis, Georgios A1 - Fischer, Uta T1 - Familiäres Zervixkarzinom – Erste Ergebnisse BT - Poster T2 - 54. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe KW - Gebärmutterhalskrebs KW - Familienanamnese Y1 - 2002 ER - TY - GEN A1 - Raptis, Georgios T1 - Übersicht über die neuen Technischen Richtlinien des BSI zum ersetzenden Scannen und zur Langzeitarchivierung BT - Vortrag T2 - Telemed 2014, Berlin, 14.10.2014 Y1 - 2014 ER - TY - GEN A1 - Raptis, Georgios T1 - Die elektronische Gesundheitskarte BT - Vortrag T2 - 7. Kommunikationsforum "Industry meets Medicine", Olpe, 5.11.2014 KW - Elektronische Gesundheitskarte Y1 - 2014 ER - TY - CHAP A1 - Spychalski, Dominik A1 - Rode, Olaf A1 - Ritthaler, Markus A1 - Raptis, Georgios T1 - Conceptual Design and Analysis of a Mobile Digital Identity for eHealth Applications T2 - 2021 IEEE EMBS International Conference on Biomedical and Health Informatics (BHI): 27-30 July 2021, Athens, Greece N2 - As mobile technology continues to improve, more and more professional services are being offered as mobile apps. This paradigm shift also affects eHealth applications. Digital identities in nation-wide eHealth infrastructures are often realized via smart cards, which however, do not support mobile applications well. In this paper we propose a concept of a mobile eID for eHealth based on smartphones with embedded secure hardware, an mobile authenticator app and an account manager as well as an Identity Provider (IdP) as backend services. The practical applicability of the concept is shown using the example of the German eHealth infrastructure. Our method generates a cryptographic key pair in secure hardware on the user’s smartphone, registers it on the IdP and uses it to authenticate on the IdP. The security of the private key and the integrity of the smartphone is also validated and attestated. The user’s established smartcard-based identity "Electronic Health Card" (EHC) forms the trust anchor. To authenticate against specialist eHealth apps the IdP issues standard-compliant OAuth2.0/OIDC tokens with a limited period of validity. Furthermore, in our security analysis we demonstrate that based on specific security requirements for smartphones and operating systems, at least the eIDAS security level "substantial" related to the technical security aspects of the system can be achieved. On the basis of this research German legislation was adjusted and "digital identities" supplementary to the smartcard-based EHC will be issued from 2023 in the German eHealth infrastructure. KW - digital identity KW - mobile security KW - eHealth KW - authentication scheme KW - identity management Y1 - 2021 U6 - https://doi.org/10.1109/BHI50953.2021.9508554 SN - 2641-3604 SP - 1 EP - 4 PB - IEEE ER - TY - GEN A1 - Raptis, Georgios T1 - Vernetzung und ubiquitäre Informationsverarbeitung – technisch-organisatorischer Datenschutz in der Arztpraxis BT - Vortrag in der 2. Fachtagung der Gesellschaft für Datenschutz und Datensicherheit e.V. (GDD), Berlin, 13.05.2014, zertifiziert von der Ärztekammer Berlin T2 - 2. Fachtagung der Gesellschaft für Datenschutz und Datensicherheit e.V. (GDD), Berlin, 13.05.2014, zertifiziert von der Ärztekammer Berlin KW - Arztpraxis KW - Datenschutz Y1 - 2014 ER -